A 'ghost town' which was once set to be a luxurious estate has gone viral on TikTok. Source: TikTok/carriejernigan1
A 'ghost town' which was once set to be a luxurious estate has gone viral on TikTok. Source: TikTok/carriejernigan1
The youngster upstaged an incredible Virat Kohli milestone in a breathtaking Indian Premier League knock.
MasterChef's Jock Zonfrillo attempted to prank contestant Justin into thinking his chicken was undercooked leaving fans stunned. Read more.
With me this morning are Cort O'Haver, the President and CEO of Umpqua Holdings Corporation; Tory Nixon, President of Umpqua Bank; and Frank Namdar, our Chief Credit Officer. After our prepared remarks, we will then take questions.
Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (EBS)
Good morning, and thanks to all of you for joining our conference call to discuss Reliance's first quarter 2021 financial results. Bill Sales, Executive Vice President, Operations, will also be available during the question-and-answer portion of this call.
Joining me today are Howard Coker, President and Chief Executive Officer; Rodger Fuller, Executive Vice President; and Julie Albrecht, Vice President and Chief Financial Officer. Finally, the operating profit change in foreign exchange and other was unfavorable by $15 million with various moving pieces mostly within SG&A expense.
POOL earnings call for the period ending March 31, 2021.
FCX earnings call for the period ending March 31, 2021.
Image source: The Motley Fool. Rush Enterprises Inc (NASDAQ: RUSHA)Q1 2021 Earnings CallApr 22, 2021, 10:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, and thank you for standing by, and welcome to the Rush Enterprises Inc.
Image source: The Motley Fool. Tractor Supply Co (NASDAQ: TSCO)Q1 2021 Earnings CallApr 22, 2021, 10:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning, ladies and gentlemen, and welcome to the Tractor Supply Company's conference call to discuss first quarter 2021 results.
Image source: The Motley Fool. Atlantic Union Bankshares Corporation (NASDAQ: AUB)Q1 2021 Earnings CallApr 22, 2021, 9:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, and thank you for standing by, and welcome to the Atlantic Union Bankshares' First Quarter 2021 Earnings Conference Call.
Kate Middleton has paid a sweet yet subtle tribute to the Queen on her 95th birthday, her first since the death of Prince Philip. Find out what it was here.
The Benign Prostatic Hyperplasia (BPH) Devices market is expected to rise owing to an increasing prevalence of benign prostatic hyperplasia and growing geriatric population globally.Los Angeles, USA, April 22, 2021 (GLOBE NEWSWIRE) -- Benign Prostatic Hyperplasia Devices Market Expected to Rise by a CAGR of 25.41% by 2026 | DelveInsightThe Benign Prostatic Hyperplasia (BPH) Devices market is expected to rise owing to an increasing prevalence of benign prostatic hyperplasia and growing geriatric population globally. DelveInsight’s Benign Prostatic Hyperplasia (BPH) Devices Market Insights, Competitive Landscape and Market Forecast -2026 provides the current and forecast market of the Benign Prostatic Hyperplasia (BPH) Devices and comprises of market trends and key competitors of Benign Prostatic Hyperplasia (BPH) Devices. DelveInsight estimated the market to grow at a high CAGR over the study period of 2018 – 2026. Key Highlights of Benign Prostatic Hyperplasia Devices Market report: Benign prostatic hyperplasia also called the enlarged prostate or prostate gland enlargement is a very common disorder that is observed in older men. The enlarged prostate can further lead to several uncomfortable urinary symptoms that involve the blockage of urine out of the bladder. The disorder is also capable of causing bladder, urinary, or kidney-related problems. However, there are is a wide range of effective treatments for prostate gland enlargement, which involves medication therapies, invasive and minimally invasive forms of therapies.The pathological prevalence of BPH is 8% in the 4th decade of life, further increasing to 30%, 50%, and 80% in 5th, 6th, and above, respectively. Out of the diagnosed patients, about one-third of these men will develop symptoms that require treatment.The report also provides the estimated patient pool population in the 7MM. In the year 2018, the total eligible patient population for benign prostatic hyperplasia in seven major markets was 7,92,10,572 in 2018 and is expected to increase by 2026. The largest population for benign prostatic hyperplasia was found in the EU5 combined.According to the estimates, in 2018, among 7MM, the EU5 had the largest BPH Devices market share of approximately 51.7%, followed by the United States.According to the estimates, the treatment rate for BPH patients is divided into pharmacological therapies (85%), surgery (13%), and medical devices (2%).iTind device (Olympus Corporation), Butterfly Medical Device (Butterfly Medical), and UroLift System (Teleflex Incorporated) are some of the key market players in the Benign Prostatic Hyperplasia Devices market. Most of these available devices are FDA-approved and are CE marked.Certain emerging devices in the market comprise Spring Implant (Zenflow) and the ClearRing device (ProArc Medical) among others.COVID-19 impacted the Benign Prostatic Hyperplasia Devices market heavily in 2020 because BPH was positioned as one of the lowest priorities of non-oncological procedures. The market saw a slow year-on-year growth as compared to previous years.On February 26, 2021, Olympus Corporation acquired Medi Tale Ltd., an Israeli manufacturer of non-surgical solutions for BPH Devices. This deal will help Olympus expand its product portfolio, making it largest player in the market.On January 27, 2021, Medeon Biodesign Inc. had announced positive clinical trial results for the XFLO minimally invasive Benign Prostatic Hyperplasia treatment device. The company announced all positive interim results of the EXPANDER-1 clinical study for their product XFLO expander system. The product when launched in future will affect the market growth. On September 23, 2020, Urotronic Inc. had received the CE Mark approval for its innovative Optilume catheter in the European region. This is accepted to boost the market for Europe in the forecast period.On April 6, 2020, the FDA had granted the de novo classification for the iTind device to treat patients suffering from Benign Prostatic Hyperplasia. Request for Sample @ Benign Prostatic Hyperplasia Devices Market Benign Prostatic Hyperplasia Devices Market Analysis and Forecast The pace of population aging around the world is also increasing dramatically. The World Health Organization estimates that by 2050, the world’s population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015. In 2015, 125 million people are aged 80 years or older and are estimated to reach 434 million people in this age group worldwide. The problem of BPH is among the most common problem in old men, hindering their daily lifestyle. The treatment algorithm for this calculated patient pool is mentioned in 2019, 2020 amended Guidelines from the American Urological Association states that drug therapy (5-alpha-reductase inhibitors (5-ARIs), alpha-1-adrenergic receptor blockers), conventional surgical therapy (Transurethral resection of the prostate (TURP), Transurethral laser surgery, Laser enucleation), and mechanically minimally invasive therapy (Prostatic urethral lift (UroLift), Spanner Temporary Prostatic Stent, iTIND) are the available treatment options given to the patients with BPH. The BPH Devices market size in 7MM will increase at a CAGR of 25.41% due to the launch of emerging medical devices and growing geriatric population. The Benign Prostatic Hyperplasia Devices market size is estimated to increase due to advancements in healthcare technology, high healthcare expenditure, and available reimbursement policies in developed countries. Along with this, the growing geriatric population globally and technological advancements are factors responsible for the growth of the Benign Prostatic Hyperplasia Devices market size at a high CAGR during the forecast period. Key Competitors in Benign Prostatic Hyperplasia Devices Market Olympus MedicalButterfly MedicalSRS MedicalTeleflex Interventional UrologyUrotronicZenflowProArc MedicalMedion Biodesign Know more about the key companies involved @ Benign Prostatic Hyperplasia Devices Market Key Companies Table of Content 1Key Insights2Report Introduction3Benign Prostatic Hyperplasia (BPH) Devices: Background and Overview4Executive Summary Of Benign Prostatic Hyperplasia5Benign Prostatic Hyperplasia: Regulatory Approval and Reimbursement Scenario6Benign Prostatic Hyperplasia Devices Market: Marketed Devices7Benign Prostatic Hyperplasia Devices Market Emerging Devices8Assumptions And Rationale For Epidemiology And Market Size Estimation9BPH Country-Wise Epidemiology10BPH Epidemiology And Patient Population11Benign Prostatic Hyperplasia Devices Market Analysis12Country-Wise Benign Prostatic Hyperplasia Devices Market Size13BPH Devices Market Analysis14Patient Journey15Supporting Associations16Case Study: BPH Medical Devices17KOL’s Views18Benign Prostatic Hyperplasia Devices Market Drivers 19Benign Prostatic Hyperplasia Devices Market Barriers 20Benign Prostatic Hyperplasia Devices Market: PEST Analysis21Appendix22DelveInsight Capabilities23Disclaimer24About DelveInsight Visit to know more about the report offerings @ Benign Prostatic Hyperplasia Devices Market The report provides valuable insight for clients venturing into the Benign Prostatic Hyperplasia Devices and acts as the source of guidance for taking strategic business decisions in the field of BPH Devices by providing a descriptive overview of pathophysiology, various diagnostic approaches, and treatment algorithm including detailed chapters for marketed products and emerging therapies. Along with this, the report has a detailed review of the market containing historical and forecasted market size in 7MM, by understanding the trends shaping and driving the global BPH Devices. This report has been prepared by DelveInsight’s analysts after a thorough secondary and primary research into the implantable cardiac monitor devices market. Analysis and estimations are done by taking into consideration the share of topmost companies and industry expert viewpoints of Benign Prostatic Hyperplasia Devices and eligible patient pool for Benign Prostatic Hyperplasia. Reach out for Consulting Solutions into Healthcare and Medical Vertical @ Healthcare Business Consulting Solutions Related Reports Airway Management Devices Market DelveInsight’s ‘Airway Management Devices -Market Insights, Competitive Landscape and Market Forecast - 2025’ report. Ambulatory Arrhythmia Monitoring Devices Market DelveInsight’s ‘Ambulatory Arrhythmia monitoring Devices-Market Insights, Competitive Landscape and Market Forecast - 2025’ report. Anesthesia Workstation Machines Market DelveInsight’s 'Anesthesia Workstation/Machines-Market Insights, Competitive Landscape and Market Forecast 2025’ report. Deep Brain Stimulation Devices Market DelveInsight’s ‘Deep Brain Stimulation Devices -Market Insights, Competitive Landscape and Market Forecast - 2025’ report. Arteriotomy Closure Devices Market DelveInsight’s ‘Arteriotomy Closure Devices -Market Insights, Competitive Landscape and Market Forecast - 2025’ report. Deep Brain Stimulation Devices Pipeline Insight DelveInsight’s, “Deep Brain Stimulation Devices Pipeline Insight and Competitive Landscape, 2020,” report provides comprehensive insights about 20+ companies and 23+ pipeline devices in deep brain stimulation (DBS) devices pipeline landscape. Vagus Nerve Stimulator Market DelveInsight’s ‘Vagus Nerve Stimulator (VNS)-Market Insights, Competitive Landscape and Market Forecast-2025’ report. Patent Foramen Ovale Closure Devices Market DelveInsight’s ‘Patent Foramen Ovale (PFO) Closure Devices-Market Insights, Competitive Landscape and Market Forecast-2025’ report. Holter Monitor Market DelveInsight’s ‘Holter Monitor (HM)-Market Insights, Competitive Landscape and Market Forecast-2025’ report. Defibrillator Market DelveInsight’s ‘Defibrillator-Market Insights, Competitive Landscape and Market Forecast-2025’ report. For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare and Biotech Blog Posts About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve. CONTACT: Contact Us Shruti Thakur email@example.com +1(919)321-6187 www.delveinsight.com
Camposol Holding PLC will announce the results for the full year 2020 on Thursday, April 29, 2021. In connection with the release, a telephone conference will be held at 9:30 a.m. (Lima) as described below. The presentation will be published at 8:30 a.m. (Lima) and will be available on the Company's website. In connection with the earnings release Samuel Dyer Coriat, CEO, and Andrés Colichón Sas, CFO, will host a conference call presentation and a Q&A session at 9:30 a.m. (Lima). To participate in the conference call, please use the following numbers: London, UK Local +0800 028 8438 US/Canada International +1 409 981 0728 Zurich, Switzerland, Local +044 580 1740 Oslo, Norway, Local +47 8001 6162 Colombia, National Free Phone +01 800 518 5094 Chile, National Free Phone +56 800 914 686 Peru, National Free Phone +51 0800 71470 Participants will be asked for their name and conference ID. The Camposol conference ID is: 2466977 Audio access for the meeting is available by dialing the above-mentioned numbers. To access the presentation webcast in connection with the conference call, please use: https://edge.media-server.com/mmc/p/5ibqjunw Participants are advised to log on to the service and check their configuration well ahead of the telephone conference commencement. For further information, please contact: Andrés Colichón Sas, CFO firstname.lastname@example.org Milagritos Olivero, Controller email@example.com Phone: +511 621 0800 Ext.: 7171 About CAMPOSOL CAMPOSOL is a vertically integrated producer of branded fresh and healthy food that offers high quality, healthy and fresh food to consumers around the world, based on a sustainable management model. CAMPOSOL’s portfolio includes superfoods like blueberries, avocados, mandarins, among others. Additionally, our international commercial platform is responsible for the commercialization of the products of these two units, with offices in the US, The Netherlands, and China. CAMPOSOL guarantees the full traceability of its products and is committed to supporting sustainable development through social and environmental responsibility policies and projects intended to increase the shared-value for all its stakeholders. On the strength of this value proposition, CAMPOSOL's commercial offices have established long-term relationships with the top worldwide supermarket chains and service them directly. CAMPOSOL is also an active member of the Global Compact since 2008. It presents annual Sustainability Reports aligned to the GRI Methodology and has achieved the following international certifications: BSCI, Global Gap, IFS, HACCP, and BRC among others. To learn more about CAMPOSOL please visit: www.camposol.com.pe
The reopening of the economy pushed Britain's consumer confidence to its highest level since the first COVID-19 restrictions and boosted consumer spending to above pre-pandemic levels, suggesting that the economy rebounded at the start of the second quarter. - Britain faces a "moment of reckoning" in the race to protect future technologies from the influence of adversaries such as China and Russia, the director of signals intelligence agency GCHQ will warn on Friday.
Bangalore batsman makes maiden ton in style. Source: IPL
GenF20 Plus by Leading Edge Health is an all natural HGH releasing system that can help men increase lean muscle mass, strength, burn body fat and enhance recovery time using powerful human growth hormone boosting ingredients, but does it actually work or are there negative side effects to know about first? GenF20 Plus Reviews GenF20 Plus Reviews New York, NY, April 22, 2021 (GLOBE NEWSWIRE) -- GenF20 Plus is an all natural HGH supplement that is formulated to help you become immune to the passage of time. By taking GenF20 Plus daily, you can purportedly boost your body’s production of human growth hormone (HGH). HGH is crucial for anti-aging, weight loss, muscle recovery, and more. Does GenF20 Plus really raise HGH levels? How does GenF20 Plus work? Find out everything you need to know about this supplement today in our review. What is GenF20 Plus? GenF20 Plus is a nutritional HGH-releasing system support supplement sold exclusively online through GenF20.co. The supplement is made to “boost your HGH levels naturally.” Just take four capsules of GenF20 Plus daily to force your body to release more human growth hormone (HGH). Typically, you need synthetic chemicals or drugs to increase HGH levels. Some doctors prescribe HGH injections for muscle or injury recovery, for example, because they’re shown to increase the body’s healing. Others take steroids illegally, injecting themselves with HGH daily to increase lean muscle mass and energy. However, GenF20 Plus is said to offer the benefits of HGH injections and medication without the downsides – or the need for a prescription. Just take GenF20 Plus daily, then activate your master gland and release muscle-building growth hormones. GenF20 Plus is marketed primarily towards people who want to increase lean muscle mass formation and develop a leaner, stronger, and more powerful body. It’s priced at around $70 for a one-month supply. How Does GenF20 Plus Work? GenF20 Plus claims to increase your body’s production of human growth hormone (HGH), leading to powerful benefits. By taking four capsules of GenF20 Plus daily, you can purportedly raise HGH levels to a point where you “become immune to the passage of time.” Your levels of HGH naturally drop as you get older. Your body doesn’t produce as much HGH, which can lead to weight gain, poor muscle recovery, and other effects. GenF20 Plus claims to counteract these natural effects of aging, leading to powerful benefits. Just take four capsules of GenF20 Plus daily, then enjoy the following benefits: Add lean muscle massTorch body fatIncrease strength and powerReduce recovery timeBoost energy levelsRepair cartilage and tissue damageElevate strength and improve physical performance Overall, the makers of GenF20 Plus claim their supplement can slow the aging process in various ways. HGH supplementation is no secret: people have been taking HGH injections for decades for this reason. However, GenF20 Plus claims to provide all of the benefits of HGH injections with none of the downsides. Instead of injecting yourself directly with HGH, you can take a supplement that support your body’s production of HGH in a different way. Why Take an HGH Supplement? Human growth hormone is proven to improve endurance, muscle mass, and performance. That’s why HGH is banned both in and out of competition. Athletes are not permitted to take HGH injections, for example, because they work similar to steroids. HGH is a hormone (it’s called human growth hormone, after all). When you take HGH drugs or injections, you’re changing your body’s hormones to give yourself a physical edge. That’s why GenF20 Plus presents itself as an alternative. By taking GenF20 Plus daily, you can enjoy the benefits of HGH injections with none of the downsides. The downsides of HGH drugs include: Synthetic: HGH drugs are synthetic. They’re made in a lab. You’re injecting yourself with synthetic hormones. GenF20 Plus contains natural ingredients instead of pure HGH. Prohibited: HGH drugs are prohibited for athletes both in and out of competition. You cannot take HGH or other steroids legally in most sports. Prescription Only: You need a prescription (or an illegal dealer) to get HGH. Doctors may prescribe HGH if you are deficient in HGH. Otherwise, you need to go the black market route in most jurisdictions. Ultimately, GenF20 Plus advertises itself as a natural, legal, and over-the-counter alternative to HGH medication. Here’s how the company describes it: “…it’s possibly the MOST exciting news in bodybuilding history…And that is… it’s possible to boost your body’s natural HGH production NATURALLY, without a prescription or breaking the law!” Just take GenF20 Plus daily to boost levels of HGH naturally, enjoying all of the benefits of HGH drugs or injections without the downsides listed above. How Does GenF20 Plus Boost Human Growth Hormone? Many bodybuilding supplements claim to support your body’s natural levels of human growth hormone (HGH). However, GenF20 Plus specifically claims to boost your body’s human growth hormone production, which would raise the levels of HGH within your body. How does GenF20 Plus do that? How can a supplement – not a drug, injection, or steroid – raise HGH levels? To do that, GenF20 Plus purportedly “activates your master gland to release muscle-building growth hormones.” The 16 ingredients in GenF20 Plus “trigger an HGH stimulating effect in your body.” Here’s how the makers of GenF20 Plus describe the system: GenF20 Plus is an all-natural formula that helps your body release more human growth hormone (HGH)The 16 ingredients in GenF20 Plus “help trigger an HGH stimulating effect in your body”HGH is secreted by the anterior lobe of your pituitary gland; the pituitary gland is often called the ‘master gland’ because it regulates the production of hormonesGenF20 Plus contains natural HGH precursors that activate the pituitary gland and stimulate the release of HGH, boosting HGH release in your body The ingredients in GenF20 Plus include amino acids, minerals, and herbal extracts – including deer velvet antler. Because of these ingredients, the company markets it as an “all-natural, HGH-releasing formula” that can “help trigger an HGH stimulating effect in your body.” GenF20 Plus is Recommended by a Medical Doctor Most testosterone boosters, HGH boosters, and similar supplements are not recommended by doctors. However, GenF20 Plus is recommended by Dr. Steven Lamm, a medical doctor and the Director of NYU’s Men’s Health Center. According to GenF20.co, Dr. Lamm will “wholeheartedly recommend” GenF20 Plus to anyone “who wants to naturally increase their HGH levels.” In other words, Dr. Lamm approves GenF20 Plus for increasing human growth hormone levels in your body. GenF20 Plus Ingredients GenF20 Plus contains amino acids, herbal extracts, vitamins, and minerals that increase HGH production in your body. These ingredients work as precursors to HGH, giving your body the ingredients it needs to make HGH on its own. Instead of directly injecting yourself with HGH (which can be illegal, requires a prescription, and is linked with side effects), you take four capsules of GenF20 Plus per day to give your body the precursors to HGH. Here is the full list of ingredients in GenF20 Plus and how they work, according to the official website: Gamma Aminobutyric Acid (GABA): The GABA in GenF20 Plus can purportedly boost HGH levels by signalling your hypothalamus to release growth hormones through your pituitary gland. GABA is an amino acid also linked to sleep, muscle recovery, and stress response. Deer Velvet Antler: Deer velvet antler is velvet from deer antlers. It’s rich with insulin-like growth factor (IGF-1), which is linked to improved cartilage, joint damage, and HGH production, among other benefits. GTF Chromium: Chromium is an essential mineral. Your body needs chromium for health and wellness. The chromium in GenF20 Plus can purportedly burn fat and increase muscle while also playing a role in the secretion of HGH. Colostrum: Colostrum is a fluid produced in the breast milk of humans and other animals. Colostrum is rich with IGF-1. GenF20 Plus contains bovine colostrum (bovine breast milk), which is “almost identical to human colostrum” but with more growth factors, according to Leading Edge Health. Pituitary (Anterior Powder): GenF20 Plus contains pituitary powders made from powdered bovine pituitary glands. By grinding the pituitary gland of a cow into a powder and taking it daily, you can purportedly enjoy powerful muscle growth and recovery, among other benefits. Other Ingredients: GenF20 Plus also contains other ingredients like astragalus root (used for centuries for energy, hormones, and stress), tribulus terrestris (for sexual energy and libido), and amino acids (like L-arginine, L-glutamine, and L-glycine), among other ingredients. GenF20 Plus also contains other ingredients like astragalus root, tribulus terrestris, L-ornithine, and others. Overall, each four capsule serving of GenF20 Plus contains over 4,000mg of formula. That’s 4,000mg of HGH precursors entering your body every day. What to Expect After Taking GenF20 Plus GenF20 Plus claims to boost levels of human growth hormone (HGH) within days or weeks, leading to noticeable changes in your body composition, workout performance, and more. According to GenF20.co, you can purportedly notice all of the following benefits of HGH within as little as three weeks of taking the formula: Increase HGH while you sleep, increase HGH during your workouts, and increase HGH throughout your dayStimulate your pituitary gland to release more HGH, even while you sleepLess joint soreness during and after workoutsAdd more weight on your bench pressBuild bigger arms more quicklyBurn belly fatGain lean muscle massImprove your overall physiqueReduce your body fat percentageIncrease motivation at the gymTrain harder with more energyGet fuller, denser muscles and more defined, chiseled abs Overall, GenF20 Plus claims to be the ultimate solution for anyone who wants better gains at the gym. If you want to enhance athletic performance, burn fat, and enjoy other benefits, then GenF20 Plus claims to be the solution you need. (SPECIAL OFFER) Click Here to Get GenF20 Plus with an Exclusive Discount Price Online Scientific Evidence for GenF20 Plus GenF20 Plus is endorsed by a medical doctor (Dr. Steven Lamm, MD), who has approved the supplement as an all-natural way to increase human growth hormone (HGH): “As a doctor, I am very critical of many of the natural anti-aging products available today. But I would wholeheartedly recommend GenF20 Plus to anyone who wants to naturally increase their HGH levels and improve their overall health as they age.” Few supplements are backed by medical doctors, and that’s doubly true in the hormone booster space. It’s hard to find any HGH boosters with a similar recommendation from a medical doctor, which is why Dr. Lamm’s recommendation is significant. GenF20 Plus is also supported by a genuine clinical trial. The supplement has completed a randomized controlled trial in 2014. In this trial, researchers found that a combination of the GenF20 Plus supplement and oral spray increased human growth hormone production. The study involved 61 healthy adults. Researchers gave GenF20 Plus to half of this group, then gave a placebo to the other half. Researchers found a statistically significant increase in insulin-like growth factor-1 (IGF-1) in the GenF20 Plus group. IGF-1 is a marker of HGH levels. Based on the results of this trial, researchers concluded that GenF20 Plus “increased serum IGF-1 levels” in the treatment group. However, researchers did not observe significant changes in other areas – like waist circumference, body mass index, body fat percentage, or lean muscle mass. Researchers believed they would have observed these changes over a longer study period. The study took place over 12 weeks (84 days). GenF20 Plus also contains ingredients like GABA. To support the use of GABA, Leading Edge Health cites this study where participants received 3,000mg of GABA or a placebo, then completed resistance training. Researcher observed significant improvements in HGH secretion in the GABA group compared to the placebo. In fact, the GABA group had 200% higher HGH levels while exercising. GenF20 Plus also contains deer antler velvet, a popular ingredient in many supplements targeting male hormones. Deer velvet antler contains IGF-1, the marker of HGH mentioned above. It’s a banned substance on the World Anti-Doping Agency’s prohibited list. However, many athletes use IGF-1 to repair cartilage, tendons, and joints, making it easier to recover. When you take deer antler extract, you get a legal source of IGF-1 to help you recover. (HUGE SAVINGS TODAY) Click Here to Get GenF20 Plus Supplement For The Lowest Price Right Now Some studies on deer antler extract has shown powerful effects, while other studies have shown no difference between deer antler velvet and a placebo. In this 2003 study, for example, researchers gave deer antler velvet or a placebo to men, then asked them to complete a resistance training program. Researchers noticed no differences between the deer velvet antler group and the placebo. Other studies, however, have been more positive. In this study, researchers analyzed the use of deer antler extract in traditional Chinese medicine, finding there was significant evidence showing it supports anti-fatigue benefits. Researchers acknowledged that deer antler was rich with IGF-1, IGF-22, and testosterone, although they also said these ingredients can be found in deer blood and other body parts. Most of the other ingredients in GenF20 Plus include amino acids like arginine, lysine, and ornithine. These amino acids have also been shown to increase growth hormone production. If your body doesn’t get the amino acids it needs daily, then your body struggles to stimulate growth hormone production. GenF20 Plus claims to solve this problem. Other Ultimately, GenF20 Plus has completed a clinical trial proving it raised IGF-1 levels in healthy men, and IGF-1 levels are associated with human growth hormone. Over the 84 day trial, men in the GenF20 Plus group raised IGF-1 levels by 28%. Because of this study and other studies, it’s possible that GenF20 Plus can legitimately boost HGH production as advertised on the official sales page. GenF20 Plus Pricing GenF20 Plus is priced at $69.95 for a one month supply. However, the price drops as low as $58 per package when ordering 6 months at a time. Here’s how pricing breaks down at GenF20.co: 1 Month Supply: $69.95 + $12.99 Shipping2 Month Supply: $134.95 + $12.99 Shipping3 Month Supply: $199.95 + Free Global Shipping4 Month Supply: $249.95 + Free Global Shipping5 Month Supply: $299.95 + Free Global Shipping6 Month Supply: $349.95 + Free Global Shipping Each package contains 120 capsules (30 servings). You take four capsules of GenF20 Plus daily (two capsules in the morning, then another two at night) to boost human growth hormone production. What is the GenF20 Plus Oral Spray? When you buy GenF20 Plus online, you receive an upsell offer for the GenF20 Plus Oral Spray. This spray can purportedly increase human growth hormone production even further using additional HGH-boosting ingredients. The GenF20 Plus Oral Spray contains alpha GPC and other amino acids. The makers of GenF20 Plus claim that alpha GPC was shown to increase HGH secretion during a clinical study, with some athletes raising HGH by 44x after taking alpha GPC. Alpha GPC is typically found in nootropic supplements to support brain health, but some studies show it can improve human growth hormone (HGH) production. The GenF20 Plus Oral Spray also contains GABA, mucuna pruriens, moomiyo extract, ornithine alpha ketoglutarate, L-glutamine, L-arginine, L-lysine, L-valine, L-isoleucine, L-tyrosine, and glycine. Together, these ingredients can purportedly provide the following benefits: A more youthful appearanceIncreased muscle toneFat loss and increased metabolismSupercharged sex driveGreater energyStrengthened immune system If you want similar effects to GenF20 Plus without needing to swallow pills, or if you want to complement the effects of GenF20 Plus, then you may want to buy the GenF20 Plus Oral Spray. 1 Month Supply: $39.95 You take 6 sprays of the GenF20 Plus Oral Spray daily in conjunction with the supplement to maximize its effects. (LOWEST PRICE ONLINE) Get GenF20 Plus HGH Booster Directly from the Official Website for the Biggest Discount GenF20 Plus Refund Policy GenF20 Plus is backed by a 67 day refund policy. If you do not increase your human growth hormone levels within 67 days of taking GenF20 Plus, or if you’re unhappy with the effects of GenF20 Plus for any reason, then you can request a refund, minus original shipping costs ($12.95 per order). Just ship the bottle of GenF20 Plus back to the manufacturer (even if it’s empty) to complete the refund process. You can learn more about the refund process here. About Leading Edge Health GenF20 Plus was made by a company named Leading Edge Health. The company makes a range of supplements targeting different health and wellness goals. Other supplements from Leading Edge Health including BrainPill (a nootropic supplement), HerSolution (a sex drive supplement for women), TestRX (a testosterone booster), and Kollagen Intensiv (an anti-aging skin cream). Dr. Steven Lamm, who has endorsed the use of GenF20 Plus for increasing HGH, is one of two medical doctors on Leading Edge Health’s board. Dr. Lamm and other medical experts advise the company on the ingredients, dosages, and formulas for maximum effect. Leading Edge Health was founded in 2001. The company is based in Victoria, British Columbia, Canada, with a registered address in Cyprus. You can contact the company via the following: Phone: 1-866-269-3487Email Form: https://www.leadingedgehealth.com/contact-us/Phone (North America): 1-866-621-6884Phone (International): 1-604-677-3533Mailing Address: 300-1095 McKenzie Avenue Victoria, BC V8P 2L5Registered Address: 171 Arch. Makariou III Ave, Vanezis Business Center, Office 401, 3027 Limassol, Cyprus) Final Word GenF20 Plus is a nutritional supplement that claims to raise human growth hormone (HGH) levels in your body by targeting your pituitary gland. By taking four capsules of GenF20 Plus daily, you can purportedly give your body the precursor ingredients it needs to increase HGH naturally. Instead of injecting yourself with steroids or getting a doctor’s prescription, you can get a similar boost to HGH with a convenient, natural supplement. GenF20 Plus is backed by a clinical trial and multiple medical doctors. Multiple studies show the ingredients in GenF20 Plus could support HGH in various ways. It may not be as powerful as HGH injections or prescription medication, but it could boost HGH production using natural ingredients. To learn more or buy GenF20 Plus online, visit GenF20.co, where all purchases are backed by a 67 day money back guarantee. Official Website: https://www.genf20.co/ Contact Details: GenF20 Plus Email: https://www.genf20.co/contact/ Phone: 1-866-269-3487 About MarketingByKevin.com This product review is published by Marketing By Kevin. Marketing By Kevin reviews are researched and formulated by a group of experienced natural health advocates with years of dedication and determination to finding the highest quality health products and wellness programs available. It should be noted that any purchase derived from this resource is done at your own peril. It is recommended to consult with a qualified professional healthcare practitioner before making an order today if there are any additional questions or concerns. Any order finalized from this release’s links are subject to the entire terms and conditions of the official website’s offer. The researched information above does not take any direct or indirect responsibility for its accuracy. Affiliate Disclosure: The links contained in this product review may result in a small commission to Marketing By Kevin if you opt to purchase the product recommended at no additional cost to you. This goes towards supporting our research and editorial team and please know we only recommend high quality products. Disclaimer: Please understand that any advice or guidelines revealed here are not even remotely a substitute for sound medical advice from a licensed healthcare provider. Make sure to consult with a professional physician before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary as the statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. Product support: https://www.genf20.co/contact/ Media Contact: firstname.lastname@example.org Attachment GenF20 Plus Reviews CONTACT: Kevin Mahoney 708-247-1324 email@example.com
Alex Smith wasn't happy with how Washington handled his improbable return.
BEIJING, CHINA, April 22, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Infobird Co., Ltd (“Infobird”), a software-as-a-service provider of innovative AI-powered, or artificial intelligence enabled, customer engagement solutions in China, announces the closing of its underwritten initial public offering of 6,250,000 ordinary shares at a public offering price of $4.00 per share, before underwriting discounts and commissions, resulting in gross proceeds of $25,000,000, before underwriting discounts and commissions and offering expenses. The offering was conducted on a firm commitment basis. All of the ordinary shares were offered by Infobird. The ordinary shares were approved for listing on The Nasdaq Capital Market and commenced trading under the ticker symbol “IFBD” on April 20, 2021. WestPark Capital, Inc. (“WestPark Capital”) acted as the book-running manager for the offering. Infobird has granted the underwriters a 45-day option to purchase up to an additional 937,500 ordinary shares at the initial public offering price, less underwriting discounts and commissions, to cover over-allotments, if any. A registration statement on Form F-1 (File No. 333-251234), as amended, including a prospectus relating to the offering, was filed with the U.S. Securities and Exchange Commission (the “SEC”) and was declared effective by the SEC on March 31, 2021. The offering of the ordinary shares was made only by means of a prospectus. Copies of the final prospectus relating to the offering may be obtained on the SEC’s website at www.sec.gov and may also be obtained from WestPark Capital, Inc., 1900 Avenue of the Stars, Suite 300, Los Angeles, CA, 90067, or by email at firstname.lastname@example.org. Before you invest, you should read the prospectus and other documents Infobird has filed or will file with the SEC for more complete information about Infobird and the offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Infobird Co., Ltd Infobird, headquartered in Beijing, China, is a software-as-a-service provider of innovative AI-powered, or artificial intelligence enabled, customer engagement solutions in China. For more information, visit Infobird’s website at www.Infobird.com. About WestPark Capital, Inc. WestPark Capital is a full-service investment bank focused on emerging growth sectors such as healthcare, software, technology, biotechnology, financial services, manufacturing, consumer products, media and telecom industries, among other categories. WestPark Capital provides a comprehensive range of corporate finance services, including initial public offerings, follow-on offerings, ATMs, Registered Direct Offerings (RD), CMPOs, private placements, SIPOs and corporate finance advisory services. Additional information about WestPark Capital is available at www.wpcapital.com or by email at email@example.com. Contacts Infobird Contact Infobird Co., LtdYimin Wu, Chief Executive Officer and Chairman of the Board of Directorswuym@infobird.com86-010-52411819 Corporate Communications: InvestorBrandNetwork (IBN) Los Angeles, California www.InvestorBrandNetwork.com 310.299.1717 Office Editor@InvestorBrandNetwork.com
Investigators have spent almost 12 months searching for Linda Stoltzfoos, 18, after she disappeared following a church service.